Head and neck cancer in 2010: Maximizing survival and minimizing toxicity

Nat Rev Clin Oncol. 2011 Feb;8(2):72-4. doi: 10.1038/nrclinonc.2010.226.


Outcomes for patients with oropharyngeal cancer are determined by their tumor characteristics and associated demographics. The role of human papilloma virus-related disease for prognosis and outcomes with chemoradiotherapy is being more clearly defined. EGFR inhibitors are used in conjunction with radiotherapy, and the importance of optimizing radiation quality and minimizing toxicity is the focus of ongoing studies.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / mortality*
  • Head and Neck Neoplasms / pathology
  • Humans
  • Survival Rate


  • Antineoplastic Agents